跳至主要内容
临床试验/NL-OMON31454
NL-OMON31454暂停2 期

MR Imaging of Lymphadenopathy in Rectal Cancer using the MR Agent Vasovist - Vasovist in Rectal Cancer

Academisch Ziekenhuis Maastricht0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
暂停
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Biopsy-proven rectal cancer
  • Age: at least 18 years
  • Surgery for rectal cancer planned within 60 days after Vasovist-enhanced MRI
  • Willing and able to undergo all study procedures
  • Written informed consent

排除标准

  • Age < 18 years
  • Pregnant and/or nursing women
  • Contra-indication for MRI
  • Previous severe allergic reaction to MR-contrast agent
  • Allergy to any of the ingredients of VAsovist
  • History of previous malignancy

研究者

相似试验